GSK BHR Study (Sont - Second Study)

• Status: Completed
• Trial end date: 2004-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to determine whether asthma control and reduced bronchial responsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS BID or FP BID in adult and adolescent patients with persistent asthma

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone

Criteria

Inclusion Criteria:

• Diagnosis of asthma

• Controller asthma medication or medium dose ICS

• Current or historical reversibility

Exclusion Criteria:

• Life-threatening asthma

• Asthma instability

• Concurrent respiratory disease

• Drug allergies

• Respiratory tract infection

• Systemic corticosteroid use

• Immunosuppressive medication use

• Postive pregnancy test

• Tobacco use

• Investigation medication use

• Site affiliation